A detailed history of Global Financial Private Client, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 2,723 shares of ABBV stock, worth $487,961. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,723
Previous 2,527 7.76%
Holding current value
$487,961
Previous $434 Million 24.03%
% of portfolio
0.21%
Previous 0.18%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$163.84 - $199.33 $32,112 - $39,068
196 Added 7.76%
2,723 $538 Million
Q2 2024

Jul 29, 2024

BUY
$154.79 - $180.76 $154 - $180
1 Added 0.04%
2,527 $434 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $639 - $728
4 Added 0.16%
2,526 $457 Million
Q4 2023

May 15, 2024

SELL
$137.6 - $154.97 $45,132 - $50,830
-328 Reduced 11.51%
2,522 $391 Million
Q3 2023

May 15, 2024

BUY
$133.59 - $154.65 $267 - $309
2 Added 0.07%
2,850 $423 Million
Q2 2023

May 15, 2024

SELL
$132.51 - $164.9 $155,699 - $193,757
-1,175 Reduced 29.21%
2,848 $385 Million
Q1 2023

May 15, 2024

BUY
$144.61 - $166.54 $144 - $166
1 Added 0.02%
4,023 $645 Million
Q4 2022

May 15, 2024

BUY
$138.31 - $165.87 $48,131 - $57,722
348 Added 9.47%
4,022 $650 Million
Q3 2022

May 15, 2024

BUY
$134.21 - $153.93 $34,894 - $40,021
260 Added 7.62%
3,674 $508 Million
Q2 2022

May 15, 2024

BUY
$137.62 - $174.96 $28,762 - $36,566
209 Added 6.52%
3,414 $525 Million
Q1 2022

May 15, 2024

BUY
$131.98 - $163.75 $104,660 - $129,853
793 Added 32.88%
3,205 $521 Million
Q4 2021

May 15, 2024

BUY
$107.43 - $135.93 $24,816 - $31,399
231 Added 10.59%
2,412 $327 Million
Q3 2021

May 15, 2024

BUY
$106.4 - $120.78 $212 - $241
2 Added 0.09%
2,181 $238 Million
Q2 2021

May 15, 2024

BUY
$105.21 - $117.21 $105 - $117
1 Added 0.05%
2,179 $249 Million
Q1 2021

May 15, 2024

SELL
$102.3 - $112.62 $1,739 - $1,914
-17 Reduced 0.77%
2,178 $236 Million
Q4 2020

May 15, 2024

BUY
$80.49 - $108.67 $1,770 - $2,390
22 Added 1.01%
2,195 $235 Million
Q3 2020

May 15, 2024

SELL
$85.91 - $100.83 $34,020 - $39,928
-396 Reduced 15.41%
2,173 $189 Million
Q2 2020

May 15, 2024

SELL
$73.37 - $98.18 $12,032 - $16,101
-164 Reduced 6.0%
2,569 $255 Million
Q4 2019

May 15, 2024

BUY
$72.13 - $90.25 $197,131 - $246,653
2,733 New
2,733 $242 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Global Financial Private Client, LLC Portfolio

Follow Global Financial Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.